FEATURED BLOGS
Jul 20, 2018
Dr. Jaime G. de la Garza-Salazar shares the story of how one of the first international Best of ASCO Meetings came to be.
Jul 18, 2018
The ASCO Annual Meeting is over, and now we return to our routines—in our clinics and hospitals, offices and operating rooms, labs and libraries, classrooms and conference rooms. I hope these stories...
Jul 18, 2018
"The challenges that affect the growth of a physician are not limited to a curriculum but are also about emotional growth." Dr. Samah Nassereddine describes the growing pains of her first year of...
Jul 16, 2018
Broadening eligibility critera for cancer clinical trials will give more patients the opportunity to contribute to scientific research.
Jul 11, 2018
Every patient with cancer deserves equal access to the highest quality care and the opportunity to participate in research.
Jul 11, 2018
ASCO CMO Dr. Richard L. Schilsky invites all cancer researchers to come together for education and networking around cancer clinical trials.
Jun 22, 2018
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as...

Advertisement

Latest Comments & Discussions


Michal Tibbits
Jul 07, 2018
Thank you for your interest in ASCO's Leadership Development Program. The application is open until September 25. Program details and...

Raju Kumar Vaddepally, MBBS, MD
Jul 06, 2018
I am interested in asco leadership development program, how can enroll in to this opportunity? I am early career oncologist.  ...

ASCO University
Jun 27, 2018
Thank you to Drs. Dunlap and Porter for leading the discussion of this case and also to all of those who contributed to the conversation!...

Jennifer Dunlap
Jun 27, 2018
Course Faculty Summary CAR-T cell therapy is a type of immunotherapy in which patient’s T cells are engineered to express a chimeric...

David Porter
Jun 27, 2018
Course Faculty Summary For patients with relapsed or refractory ALL, allogeneic SCT offers a low chance of cure while treatment with...

Pages

Most Read

This was a patient who needed to do cancer her way, and making it about me was not going to work.
Monica M. Bertagnolli, MD, FACS, FASCO, has always been a trailblazer, both in her field and in the ranks of leadership. Her next role? 2018–2019 ASCO President.
Dr. Arjun Gupta reconsidered an order (and the evidence) for a neutropenic diet when it negatively affected his patient's quality of life.  
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as a modifiable risk for cancer, and more.
Read more to answer the following questions: 1.  What treatment options would be considered next? 2.  What are the clinical features and molecular hallmarks of Ph-like ALL?

Tweets from ASCO

Tweets from Oncology Community